GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Market Cap

DuoGenic StemCells (ROCO:7607) Market Cap : NT$811.18 Mil (As of Dec. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DuoGenic StemCells's share price for the quarter that ended in Jun. 2024 was NT$35.7. DuoGenic StemCells's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 30.55 Mil. Therefore, DuoGenic StemCells's market cap for the quarter that ended in Jun. 2024 was NT$1,090.74 Mil.

DuoGenic StemCells's quarterly market cap increased from Jun. 2023 (NT$974.64 Mil) to Dec. 2023 (NT$1,099.91 Mil) but then declined from Dec. 2023 (NT$1,099.91 Mil) to Jun. 2024 (NT$1,090.74 Mil).

DuoGenic StemCells's annual market cap stayed the same from Dec. 2021 (NT$0.00 Mil) to Dec. 2022 (NT$0.00 Mil) but then increased from Dec. 2022 (NT$0.00 Mil) to Dec. 2023 (NT$1,099.91 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DuoGenic StemCells's Enterprise Value for Today is NT$797.78 Mil.

DuoGenic StemCells Market Cap Historical Data

The historical data trend for DuoGenic StemCells's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Market Cap Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23
Market Cap
- - 1,099.91

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial - - 974.64 1,099.91 1,090.74

Competitive Comparison of DuoGenic StemCells's Market Cap

For the Biotechnology subindustry, DuoGenic StemCells's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DuoGenic StemCells's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DuoGenic StemCells's Market Cap distribution charts can be found below:

* The bar in red indicates where DuoGenic StemCells's Market Cap falls into.


DuoGenic StemCells Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

DuoGenic StemCells's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$36*30.553
=NT$1,099.91

DuoGenic StemCells's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=NT$35.7*30.553
=NT$1,090.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DuoGenic StemCells  (ROCO:7607) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

DuoGenic StemCells Market Cap Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Market Cap
Comparable Companies
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
Website
https://www.dgsc.com.tw
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines